Scientific Publications
SNIPR Biome has research findings published in Nature Biotechnology / 05.23
SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
Cell-free synthesis of infective phages from in vitro assembled phage genomes for efficient phage engineering and production of large phage libraries / 08.24
This study investigates an approach to phage engineering based on phage rebooting and compares selected methods of assembly and rebooting of phage genomes.
Addressing the Research and Development Gaps in Modern Phage Therapy / 03.24
We review the current state of phage therapy research, including major operational, epistemic, and biological challenges for phage R&D, and discuss some new approaches to developing the technology motivated by recent breakthroughs such as artificial intelligence and synthetic phage production.
Bacterial defense systems exhibit synergistic anti-phage activity / 02.24
We investigated >100 defense systems in 42,925 bacterial genomes and identified numerous instances of their non-random co-occurrence and negative association.
Our Granted US and European Patents
06.02.2024
Propogator Cells and Methods for Propagating Phage (US11891629)
26.12.2023
Single-Vector Type I Vectors (US11851663)
19.12.2023
Altering Microbial Populations and Modifying Microbiota (US11844760)
17.10.2023
Treating and Preventing Microbial Infections (US11788085)
09.05.2023
Treating and Preventing Microbial Infections (US11643653)
09.05.2023
Altering Microbial Populations and Modifying Microbiota (US11642363)
14.02.2023
Single-Vector Type I Vectors (US11578333)
10.01.2023
Altering Microbial Populations and Modifying Microbiota (US11547716)
06.12.2022
Altering Microbial Populations and Modifying Microbiota (US11517582)
01.11.2022
Treating and Preventing Microbial Infections (US11485973)
18.10.2022
Selectively Altering Microbiota for Immune Modulation (US11471531)
18.10.2022
Selectively Altering Microbiota for Immune Modulation (US11471530)
23.08.2022
Treating and Preventing Microbial Infections (US11421227)
02.08.2022
Altering Microbial Populations and Modifying Microbiota (US11400110)
07.06.2022
Selectively Altering Microbiota for Immune Modulation (US11351252)
05.04.2022
Selectively Altering Microbiota for Immune Modulation (US11291723)
15.12.2021
Altering Microbial Populations and Modifying Microbiota (EP3291679)
19.10.2021
Altering Microbial Populations and Modifying Microbiota (US11147830)
12.10.2021
Selectively Altering Microbiota for Immune Modulation (US11141481)
23.03.2021
Selectively Altering Microbiota for Immune Modulation (US10953090)
16.02.2021
Treating and Preventing Microbial Infections (US10920222)
25.08.2020
Recombinogenic nucleic acid strands in situ (US10751427)
09.08.2020
Selectively Altering Microbiota for Immune Modulation (US10765740)
09.01.2020
Treating and Preventing Microbial Infections (US10760075)
04.21.2020
Altering Microbial Populations and Modifying Microbiota (US10624349)
03.31.2020
Selectively Altering Microbiota for Immune Modulation (US10603379)
03.24.2020
Selectively Altering Microbiota for Immune Modulation (US10596255)
03.10.2020
Altering Microbial Populations and Modifying Microbiota (US10582712)
02.18.2020
Altering Microbial Populations and Modifying Microbiota (US10561148)
01.07.2020
Altering Microbial Populations and Modifying Microbiota (US10524477)
12.17.2019
Altering Microbial Populations and Modifying Microbiota (US10506812)
11.30.2019
Altering Microbial Populations and Modifying Microbiota (US10463049)
07.30.2019
Selectively Altering Microbiota for Immune Modulation (US10363308)
05.28.2019
Selectively Altering Microbiota for Immune Modulation (US10300138)
05.28.2019
Selectively Altering Microbiota for Immune Modulation (US10300139)
02.05.2019
Selectively Altering Microbiota for Immune Modulation (US10195273)
07.11.2017
Altering Microbial Populations and Modifying Microbiota (US9701964)